San Diego, CA -- (SBWIRE) -- 08/06/2013 -- An investigation on behalf of investors of TearLab Corp (NASDAQ:TEAR)) shares over potential securities laws violations by TearLab and certain of its directors and officers in connection certain financial statements was announced.

Investors who purchased shares of TearLab Corp (NASDAQ:TEAR) have certain options and should contact the Shareholders Foundation at mail(at)shareholdersfoundation.com or call +1(858) 779 - 1554.

The investigation by a law firm focuses on possible claims on behalf of purchasers of the securities of TearLab Corp (NASDAQ:TEAR) concerning whether a series of statements by TearLab Corp regarding its business, its prospects and its operations were materially false and misleading at the time they were made.

TearLab Corp reported that its annual Total Revenue rose from $0.87 million in 2009 to $3.96 million in 2012, while its Net Loss increased from $4.39 million in 2009 to $19.31 million in 2012. Shares of TearLab Corp (NASDAQ:TEAR) grew from $1.01 in early 2010 to as high as $14.73 per share.

On August 1, 2013, an article was published that alleged that some of the doctors listed on the website of TearLab Corp were providers of its diagnostic test for dry eye disease ("DED") no longer use the machine and had already returned it.
Shares of TearLab Corp (NASDAQ:TEAR) declined from $14.85 per share on July 30, 2013, to $11.40 per share on August 2, 2013.

On August 5, 2013, NASDAQ:TEAR shares closed at $12.73 per share.

Those who purchased shares of TearLab Corp (NASDAQ:TEAR) have certain options and should contact the Shareholders Foundation.

Contact:
Shareholders Foundation, Inc.
Trevor Allen
3111 Camino Del Rio North - Suite 423
92108 San Diego
Phone: +1-(858)-779-1554
Fax: +1-(858)-605-5739
mail@shareholdersfoundation.com